DrugPatentWatch Database Preview
BONJESTA Drug Profile
Which patents cover Bonjesta, and when can generic versions of Bonjesta launch?
Bonjesta is a drug marketed by Duchesnay and is included in one NDA. There are five patents protecting this drug and one Paragraph IV challenge.
This drug has sixty-one patent family members in thirty-two countries.
The generic ingredient in BONJESTA is doxylamine succinate; pyridoxine hydrochloride. There are fourteen drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the doxylamine succinate; pyridoxine hydrochloride profile page.
Summary for BONJESTA
| International Patents: | 61 |
| US Patents: | 5 |
| Applicants: | 1 |
| NDAs: | 1 |
| Suppliers / Packagers: | 1 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for BONJESTA |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for BONJESTA |
| DailyMed Link: | BONJESTA at DailyMed |
Recent Litigation for BONJESTA
Identify potential future generic entrants
District Court Litigation
| Case Name | Date |
|---|---|
| Duchesnay Inc. v. Mylan Pharmaceuticals Inc. | 2015-05-13 |
| Michael R Mastro | 2009-07-10 |
Pharmacology for BONJESTA
| Ingredient-type | Vitamin B 6 Analogs/Derivatives |
| Drug Class | Antihistamine Vitamin B6 Analog |
| Mechanism of Action | Histamine Receptor Antagonists |
Paragraph IV (Patent) Challenges for BONJESTA
| Tradename | Dosage | Ingredient | NDA | Submissiondate |
|---|---|---|---|---|
| BONJESTA | TABLET, EXTENDED RELEASE;ORAL | doxylamine succinate; pyridoxine hydrochloride | 209661 | 2018-08-28 |
US Patents and Regulatory Information for BONJESTA
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Duchesnay | BONJESTA | doxylamine succinate; pyridoxine hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 209661-001 | Nov 7, 2016 | RX | Yes | Yes | Start Trial | Start Trial | Y | Start Trial | |||
| Duchesnay | BONJESTA | doxylamine succinate; pyridoxine hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 209661-001 | Nov 7, 2016 | RX | Yes | Yes | Start Trial | Start Trial | Y | Start Trial | |||
| Duchesnay | BONJESTA | doxylamine succinate; pyridoxine hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 209661-001 | Nov 7, 2016 | RX | Yes | Yes | Start Trial | Start Trial | Y | Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for BONJESTA
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Duchesnay | BONJESTA | doxylamine succinate; pyridoxine hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 209661-001 | Nov 7, 2016 | Start Trial | Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for BONJESTA
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Hong Kong | 1197035 | Start Trial |
| Taiwan | I595874 | Start Trial |
| Greece | 1004641 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
